Presentation Information
[2P-900]Development of Vitamin K Derivatives with 3CL Protease and RdRp Inhibitory Effects for the Treatment of COVID-19
○Mayu Hayakawa1, Ryohoto Koharazawa1, Taiki Honma1, Kazuki Takeda2, Yoshitomo Suhara1, Yoshihisa Hirota1 (1. Department of Bioscience and Engineering, College of Systems Engineering and Science, Shibaura Institute of Technology, 2. School of Veterinary Medicine, Kitazato University, Japan.)
Password required to view
orLog in
Comment
To browse or post comments, you must log in.Log in